Apogem Capital LLC Aurinia Pharmaceuticals Inc. Transaction History

Apogem Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$10.93 - $23.55 $109,398 - $235,711	-10,009 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$10.0 - $14.52 $177,510 - $257,744	-17,751 Reduced 63.94%	10,009 $130,000
Q1 2021 May 14, 2021	SELL	$12.3 - $18.73 $40,221 - $61,247	-3,270 Reduced 10.54%	27,760 $360,000
Q4 2020 Feb 16, 2021	BUY	$12.94 - $16.05 $401,528 - $498,031	31,030 New	31,030 $429,000

214

58.3M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Apogem Capital LLC, based on Form 13F filings with the SEC.

Stay updated on Apogem Capital LLC with notifications on news.